Bryophyllum pinnatum (syn. Kalanchoe pinnata), a plant native to Madagascar, was introduced into anthroposophic medicine in the early 20th century. In recent years, a number of investigations were conducted on the chemical composition, pharmacological properties, and clinical efficacy of Bryophyllum. Here the phytochemistry, and pharmacological and clinical data are reviewed. With respect to pharmacology, a special focus was put on properties related to the use in anthroposophic medicine as a treatment for “hyperactivity diseases”, including preterm labor, restlessness, and sleep disorders. Recent studies suggest that B. pinnatum has also potential as a treatment option in patients suffering from overactive bladder syndrome. Tolerability of Bryophyllum is addressed, and existing toxicological data are discussed in relation to bufadienolides contained in Bryophyllum. Open questions regarding the use of Bryophyllum are also discussed.
GehrigH., GaussmannO., MarxH., SchwarzottD., KlugeM. (2001) Molecular phylogeny of the genus Kalanchoe (Crassulaceae) inferred from nucleotide sequences of the ITS-1 and ITS-2 regions. Plant Science, 160, 827–835.
BalzerG.Goethes Bryophyllum. Ein Beitrag zu seiner Pflanzenpharmakologie. Berlin-Kleinmachnow. Gartenverlag GmbH. 1949
7.
FürerK., RaithM., BrenneisenR., MennetM., Simões-WüstA.P., von MandachU., HamburgerM., PotteratO. (2013) Two new flavonol glycosides and a metabolite profile of Bryophyllum pinnatum, a phytotherapeutic used in obstetrics and gynaecology. Planta Medica, 79, 1565–1571.
8.
McKenzieR.A., FrankeF.P., DunsterP.J. (1987) The toxicity to cattle and bufadienolide content of six Bryophyllum species. Australian Veterinary Journal, 64, 298–301.
9.
SupratmanU., FujitaT., AkiyamaK., HayashiH. (2000) New insecticidal bufadienolide, bryophyllin C, from Kalanchoe pinnata. Bioscience, Biotechnology, and Biochemistry, 64, 1310–1312.
10.
SupratmanU., FujitaT., AkiyamaK., HayashiH., MurakamiA., SakaiH., KoshimizuK., OhigashiH. (2001) Anti-tumor promoting activity of bufadienolides from Kalanchoe pinnata and K. daigremontiana x tubiflora. Bioscience, Biotechnology, and Biochemistry, 65, 947–949.
11.
OufirM., SeilerC., GerodettiM., GerberJ., FürerK., Mennet-Von EiffM., ElsasS.M., BrenneisenR., von MandachU., HamburgerM., PotteratO. (2015) Quantification of bufadienolides in Bryophyllum pinnatum leaves and manufactured products by UHPLC-ESIMS/MS. Planta Medica, 81, 1190–1197.
12.
GaindK.N., GuptaR.L. (1973) Phenolic components from the leaves of Kalanchoe pinnata. Planta Medica, 23, 149–153.
13.
YeY-Y, YangY-J, XiaM-Y, LiuD-C, DaiY-H, ZhengL., WangD. (2013) Chemical constituents in herbs of Bryophyllum pinnatum. Zhongcaoyao, 44, 2642–2646.
14.
MuzitanoM.F., TinocoL.W., GuetteC., KaiserC.R., Rossi-BergmannB., CostaS.S. (2006) The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata. Phytochemistry, 67, 2071–2077.
15.
TatsimoS.J., Tamokou JdeD., HavyarimanaL., CsuporD., ForgoP., HohmannJ., KuiateJ.R., TaneP. (2012) Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum. BMC Research Notes, 5, 158.
DarmawanA., Megawati, FajriahS. (2013) 3′,4′-Dimethoxyquercetin, a flavonol compound isolated from Kalanchoe pinnata. Journal of Applied Pharmaceutical Sciences, 3, 88–90.
18.
NascimentoL.B., Leal-CostaM.V., MenezesE.A., LopesV.R., MuzitanoM.F., CostaS.S., TavaresE.S. (2015) Ultraviolet-B radiation effects on phenolic profile and flavonoid content of Kalanchoe pinnata. Journal of Photochemistry and Photobiology B, 148, 73–81.
19.
CoutinhoM.A.S., MuzitanoM.F., CruzE.A., BergonziM.C., KaiserC.R., TinocoL.W., BiliaA.R., VincieriF.F., Rossi-BergmannB., CostaS.S. (2012) Flowers from Kalanchoe pinnata are a rich source of T cell-suppressive flavonoids. Natural Product Communications, 7, 175–178.
20.
OgungbamilaF.O., OnavunmiG.O., AdeosunO. (1997) A new acylated flavan-3-ol from Bryophyllum pinnatum. Natural Products Letters, 10, 201–203.
21.
OkwuD.E., NnamdiF.U. (2011) Two novel flavonoids from Bryophyllum pinnatum and their antimicrobial activity. Journal of Chemical and Pharmaceutical Research, 3, 1–10.
22.
FürerK., Simões-WüstA.P., von MandachU., HamburgerM., PotteratO. (2016) Bryophyllum pinnatum, a plant used in anthroposophic medicine: A review on constituents, pharmacological activities and clinical efficacy. Planta Medica, 82, 930–941.
23.
(a) KambojA., SalujaA.K. (2009) Bryophyllum pinnatum (Lam.) Kurz.: phytochemical and pharmacological profile: a review. Pharmacognosy Reviews, 3, 364–374; (b) Costa SS, Muzitano MF, Camargo LMM, Coutinho MAS. (2008) Therapeutic potential of Kalanchoe species: Flavonoids and other secondary metabolites, Natural Product Communications, 3, 2151–2164.
24.
KienleG.S., AlbonicoH.U., BaarsE., HamreH.J., ZimmermannP., KieneH. (2013) Anthroposophic medicine: An integrative medical system originating in Europe. Global Advances in Health and Medicine, 6, 20–31.
25.
GirkeM.Innere Medizin. Grundlagen und therapeutische Konzepte der Anthroposophischen Medizin. Berlin. Salumed. 2010.
26.
RistL., Seitz-GwehenbergerB., KukckA., von MandachU. (2006) Zum Verständnis von Bryophyllum als Planze und Medikament. Der Merkurstab, 4, 298–307.
27.
LeuenbergerM. (2006) Bryophyllum in der Frauenheilkunde. Weleda Ärzteforum, 16, 1–8.
von MandachU., Simões-WüstA-P, KuckA., BetschartC. (2011) Bryophyllum pinnatum in der Geburtshilfe und Gynäkologie. Wirksamkeit und Verträglichkeit. info@gynäkologie, 3, 16–19.
30.
HassauerW., SchreiberK., von der DeckenD. (1985) Bryophyllum - Ein neuer Weg in der tokolytischen Therapie. Erfahrungsheilkunde, 34, 683–687.
31.
Vademecum Anthroposophische Arzneimittel. (2013) Hrsg.: Gesellschaft Anthroposophischer Ärzte in Deutschland und der Medizinischen Sektion der Freien Hochschule für Geisteswissenschaft, Dornach/Schweiz. 3th ed. Berlin: Der Merkurstab, 178–183.
32.
Simões-WüstA.P., JeschkeE., MennetM., SchnelleM., MatthesH., von MandachU. (2012) Prescribing pattern of Bryophyllum preparations among a network of anthroposophic physicians. Forschende Komplementmedizin, 19, 293–301.
33.
FürerK., Simões-WuestA.P., WinklerA., AmslerN., SchnelleM., von MandachU. (2015) Die Anwendung von Bryophyllum pinnatum-Präparaten in der Geburtshilfe und Gynäkologie – eine multizentrische prospektive Beobachtungsstudie. Forschende Komplementärmedizin, 22, 231–236.
34.
DaubE. (1989) Vorzeitige Wehentätigkeit. Ihre Behandlung mit pflanzlichen Substanzen, eine klinische Studie.Urachhaus, Stuttgart.
35.
VilaghyI. (2002) Senkung der Frühgeburtenrate mit Phytotherapie-Ergebnisse aus der Praxis. Therapeutische Umschau, 59, 696–701.
36.
PlanggerN., RistL., ZimmermannR., von MandachU. (2006) Intravenous tocolysis with Bryophyllum pinnatum is better tolerated than beta-agonist application. European Journal of Obstetrics & Gynecology and Reproductive Biology, 124, 168–172.
37.
WächterR. (2010) Klinische Wirksamkeit, Pharmakologie und Analytik von Bryophyllum pinnatum [dissertation]. University of Basel.
38.
GwehenbergerB., RistL., HuchR., von MandachU. (2004) Effect of Bryophyllum pinnatum versus fenoterol on uterine contractility. European Journal of Obstetrics & Gynecology and Reproductive Biology, 113, 164–171.
39.
WächterR., BrenneisenR., HamburgerM., MennetM., SchnelleM., WorelA.M., Simões-WustA.P., von MandachU. (2011) Leaf press juice from Bryophyllum pinnatum (Lamarck) Oken induces myometrial relaxation. Phytomedicine, 19, 74–82.
40.
Simões-WüstA.P., GraosM., DuarteC.B., BrenneisenR., HamburgerM., MennetM., RamosM.H., SchnelleM., WächterR., WorelA.M., von MandachU. (2010) Juice of Bryophyllum pinnatum (Lam.) inhibits oxytocin-induced increase of the intracellular calcium concentration in human myometrial cells. Phytomedicine, 17, 980–986.
41.
HaylenB.T., de RidderD., FreemanR.M., SwiftS.E., BerghmansB., LeeJ., MongaA., PetriE., RizkD.E., SandP.K., SchaerG.N. (2010) An International Urogynecological and Urodynamics Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics, 29, 4–20.
42.
BetschartC., von MandachU., SeifertB., ScheinerD., PerucchiniD., FinkD., GeissbuhlerV. (2013) Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine, 20, 351–358.
43.
SchulerV., SuterK., FürerK., EberliD., HorstM., BetschartC., BrenneisenR., HamburgerM., MennetM., SchnelleM., Simões-WüstA.P., von MandachU. (2012) Bryophyllum pinnatum inhibits detrusor contractility in porcine bladder strips–a pharmacological study towards a new treatment option of overactive bladder. Phytomedicine, 19, 947–951.
44.
FürerK., EberliD., BetschartC., BrenneisenR., De MieriM., HamburgerM., Mennet-Von EiffM., PotteratO., SchnelleM., Simões-WüstA.P., von MandachU. (2015) Inhibition of porcine detrusor contractility by the flavonoid fraction of Bryophyllum pinnatum - a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome. Phytomedicine, 22, 158–164.
45.
Lambrigger-SteinerC., Simões-WüstA.P., KuckA., FürerK., HamburgerM., von MandachU. (2014) Sleep quality in pregnancy during treatment with Bryophyllum pinnatum: an observational study. Phytomedicine, 21, 753–757.
46.
Simões-WüstA.P., HassaniT.A., Muller-HubenthalB., PittlS., KuckA., MedenH., EberhardJ., DeckerM., FürerK., von MandachU. (2015) Sleep quality improves during treatment with Bryophyllum pinnatum: An observational study on cancer patients. Integrated Cancer Therapies, 14, 452–459.
47.
YemitanO.K., SalahdeenH.M. (2005) Neurosedative and muscle relaxant activities of aqueous extract of Bryophyllum pinnatum. Fitoterapia, 76, 187–193.
48.
PalS., SenT., ChaudhuriA.K. (1999) Neuropsychopharmacological profile of the methanolic fraction of Bryophyllum pinnatum leaf extract. Journal of Pharmacy and Pharmacology, 51, 313–318.
49.
WagnerH., FischerM., LotterH. (1985) New bufadienolides from Kalanchoe daigremontiana Hamet et Perr. (Crassulaceae). Zeitschrift für Naturforschung B, 40B, 1226–1227.
50.
HosomiJ.K., GhelmanR., QuintinoM.P., de SouzaE., NakamuraM.U., MoronA.F. (2014) Effects of chronic Bryophyllum pinnatum administration on Wistar rat pregnancy. Forschende Komplementärmedizin, 21, 184–189.
51.
WagnerH., LotterH., FischerM. (1986) The toxic and sedative bufadienolides of Kalanchoe daigremontiana Hamet et Perr. Helvetica Chimica Acta, 69, 359–367.
52.
ScholtysikG., WagnerH., FischerM., RueggU. (1986) Cardiac glycoside-like effects of a bufadienolide extracted from Kalanchoe daigremontiana. In Cardiac glycosides 1785–1985.ErdmannE., GreeffK., SkouJ.C. (eds). Springer, Berlin, Heidelberg, Germany, 171–179.
53.
AdesanwoJ.K., RajiY., OlaleyeS.B., OnasanwoS.A., FadareO.O., IgeO.O., OdusanyaO.O. (2007) Antiulcer activity of methanolic extract of Bryophyllum pinnatum in rats. Journal of Biological Sciences, 7, 409–412.
54.
DevbhutiD., GuptaJ.K., DevbhutiP., BoseA. (2008) Phytochemical and acute toxicity study on Bryophyllum calycinum Salisb. Acta Poloniae Pharmaceutica, 65, 501–504.
55.
PalS., SenT., ChaudhuriA.K. (1999) Neuropsychopharmacological profile of the methanolic fraction of Bryophyllum pinnatum leaf extract. Journal of Pharmacy and Pharmacology, 51, 313–318.
